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Introduction
In response to threats to genome integrity, cells have evolved 
elaborate pathways for sensing and repairing DNA damage. 
The DNA damage response infiltrates all aspects of cell physi-
ology, including basic processes such as transcription. The in-
volvement of components of the transcriptional machinery with 
DNA damage pathways has a long history, with members of the 
RNA polymerase II–associated basal transcription machinery 
impacting  both  nucleotide  excision  repair  (Lainé  and  Egly, 
2006)  and  double-strand  break  responses  (Buchmann  et  al., 
2004; Derheimer et al., 2007).
The Integrator complex was initially characterized as an 
RNA polymerase II C-terminal domain–binding factor involved 
in the 3 processing of small nuclear RNAs (snRNAs; Baillat 
et al., 2005). The Integrator complex contains at least 12 subunits 
whose individual contributions to snRNA processing or broader 
cellular functions remain largely uncharacterized. The snRNA 
processing  activity  is  provided  by  a  -lactamase  domain  in 
INTS11, which shows homology to the cleavage-specific poly-
adenylation factor 73 (Baillat et al., 2005). INTS1 and -5 are 
also required for snRNA processing (Dominski et al., 2005; Tao 
et al., 2009), but the functions of other INTS proteins remain 
largely unexplored. INTS6 was initially described as a tumor 
suppressor (Wieland et al., 1999), and INTS1 is required for 
early  embryonic  development  (Hata  and  Nakayama,  2007). 
Whether these functions are Integrator dependent has not been 
addressed,  and  neither  Integrator  nor  its  individual  subunits 
have been linked to DNA damage responses.
The  ataxia  telangiectasia  mutated  (ATM)  kinase  is  a 
master regulator of the response to DNA double-strand breaks, 
phosphorylating multiple targets to institute cell cycle arrest 
(e.g., phosphorylation of p53 and CHK2) and coordinate the re-
pair of DNA damage (e.g., phosphorylation of BRCA1, H2AX, 
and the MRN [Mre11–Rad50–Nbs1] complex; Lavin, 2007). 
Recently, the oligonucleotide/oligosaccharide-binding (OB) 
fold protein human SSB1 (single-stranded binding protein 1 
[hSSB1]; OBFC2B/NABP2) was identified as a key player in 
the ATM-mediated response to DNA double-strand breaks (Kang 
et al., 2006; Richard et al., 2008), with ATM-mediated phos-
phorylation of Thr117 stabilizing hSSB1. Although hSSB1 is 
an ATM target, hSSB1 function is required for activation of ATM 
kinase activity after DNA damage. hSSB1 localizes directly to 
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uman  SSB1  (single-stranded  binding  protein  1 
[hSSB1]) was recently identified as a part of the 
ataxia  telangiectasia  mutated  (ATM)  signaling 
pathway. To investigate hSSB1 function, we performed 
tandem affinity purifications of hSSB1 mutants mimick-
ing  the  unphosphorylated  and  ATM-phosphorylated 
states. Both hSSB1 mutants copurified a subset of Inte-
grator complex subunits and the uncharacterized protein 
LOC58493/c9orf80  (henceforth  minute  INTS3/hSSB-
associated  element  [MISE]).  The  INTS3–MISE–hSSB1 
complex plays a key role in ATM activation and RAD51 
recruitment to DNA damage foci during the response to 
genotoxic  stresses.  These  effects  on  the  DNA  damage 
response are caused by the control of hSSB1 transcrip-
tion via INTS3, demonstrating a new network controlling 
hSSB1 function.
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little difference in the associated proteins of hSSB1 T117A 
and T117E. Both proteins associated with a subset of members 
of the Integrator complex and LOC58493/c9orf80, a novel, 
uncharacterized 11-kD protein which we have named minute 
INTS3/hSSB-associated element (MISE; Fig. 1 B) to reflect 
its small size and association with INTS3 and hSSB1. The   
association of the hSSB1 mutants with INTS3 and MISE was 
particularly robust, as demonstrated by both silver staining 
and  their  normalized  spectral  abundance  factors  (NSAFs;   
Zybailov et al., 2007). Although large amounts of INTS3 were 
found via MudPIT analysis, only a few peptides were found 
for other members of the Integrator complex, including (in   
order of NSAFs) INTS6, -5, -8, and -1, and no peptides were 
found for INTS11, the catalytic subunit of the Integrator com-
plex which is required for snRNA processing. The combina-
tion of the large NSAF values for hSSB1, INTS3, and MISE, 
in conjunction with the absence of the INTS11, suggested that 
the hSSB1–INTS3 complex is unique and separate from the 
previously described Integrator complex (Baillat et al., 2005). 
Therefore, we will refer to this complex as the INTS3–MISE–
hSSB1 (IMS1) complex.
double-strand breaks and stimulates strand invasion by RAD51, 
which is consistent with a function in DNA repair by homolo-
gous recombination (HR). Consequently, the loss of hSSB1 
results in radiosensitivity and genomic instability.
Despite the identification of hSSB1 as a member of the 
ATM pathway, the molecular mechanisms controlling hSSB1 
functions remain to be elucidated. In this study, we identify a 
novel hSSB1-containing complex that is required for an effec-
tive response to DNA damage.
Results and discussion
hSSB1 binds a novel  
INTS3-containing complex
To investigate the function of hSSB1, hSSB1 mutants mimick-
ing the constitutively unphosphorylated (T117A) or phosphor-
ylated  (T117E)  protein  were  tandem  affinity  purified  from 
HEK293T cells (Fig. 1 A; Nakatani and Ogryzko, 2003). Con-
sistent with previously reported stability differences (Richard 
et al., 2008), less T117A was purified compared with T117E. 
However, MudPIT analysis (Washburn et al., 2001) revealed 
Figure 1.  hSSB1 binds INTS3 and MISE. (A) HEK293T cells transfected with Flag-HA–hSSB1 T117A or Flag-HA–hSSB1 T117E were harvested for tandem 
affinity purification. 5% of the Flag-HA–hSSB1 T117A, Flag-HA–hSBB1 T117E, and control purifications was subjected to SDS-PAGE and silver staining.   
(B) MudPIT analysis of the purifications in A, listing unique peptides, total peptides, and NSAFs for the indicated proteins. (C) U-2 OS cell lysates were immuno-
precipitated for the indicated proteins, separated by SDS-PAGE, and Western blotted as indicated. (A and C) Molecular mass is indicated in kilodaltons. 
(D) HEK293T cells were mock transfected or transfected with Myc-MISE. 48 h after transfection, cells were harvested, and lysates were immunoprecipitated 
as indicated, before SDS-PAGE and Western blotting as indicated. IP, immunoprecipitation; WCL, whole cell lysate.27 IMS1 FUNCTIONS IN THE DNA DAMAGE RESPONSE • Skaar et al.
tag (Fig. 1 D). Myc-MISE reciprocally coimmunoprecipitated 
with both hSSB1 and INTS3. The relatively small amount of 
Myc-MISE coimmunoprecipitating with hSSB1 and INTS3 is 
likely caused by the requirement of Myc-MISE to displace en-
dogenous MISE. In conjunction with the NSAF data, which show 
that hSSB1 complexes contain 20 times more MISE than the an-
cillary INTS proteins, this result supports the conclusion that the 
core of this unique complex contains hSSB1, INTS3, and MISE.
IMS1 complex formation is independent of 
DNA damage
Because hSSB1 functions in the DNA damage response, the reg-
ulation of the IMS1 complex by DNA damage was investigated. 
Normal human fibroblasts (NHFs) were treated with doxorubi-
cin before harvesting and immunoprecipitation for endogenous 
hSSB1 and INTS3 and -11 (Fig. 2 A). As predicted by the bind-
ing of both the T117A and T117E mutants to INTS3, hSSB1 and 
INTS3 were reciprocally coimmunoprecipitated in the presence 
or absence of DNA damage. The INTS3–hSSB1 interaction was 
insensitive to sonication and benzonase treatment, making it un-
likely to be mediated through DNA or RNA. Similar to the re-
sults from U-2 OS cells (Fig. 1 C), both hSSB1 and INTS3 bound 
lesser amounts of INTS6 and INTS5 and did not bind INTS4 
(Fig. 2 A). INTS11 failed to coimmunoprecipitate with either 
hSSB1 or INTS3 under either condition, although it coimmuno-
precipitated INTS4.
The interaction of INTS3 and hSSB1 is independent of 
DNA damage and Thr117 phosphorylation, so we explored the 
interaction via INTS3 and hSSB1 truncation mutants. INTS3 
To  investigate  this  complex,  immunoprecipitations  of 
endogenous hSSB1 and INTS3 and -11 were performed from a 
variety of cell types (Figs. 1 C and 2 A and not depicted). In 
accordance with the MudPIT NSAF values, endogenous hSSB1 
and INTS3 coimmunoprecipitated each other, while coimmuno-
precipitating smaller amounts of INTS6, -5, and -1. (INTS3 binds 
the faster-migrating and most abundant band detected by hSSB1 
antibodies; hSSB1 knockdown suggests that the slower-migrating 
band is nonspecific or a splice variant that is insensitive to the 
siRNA [Fig. S1 A].) Notably, neither hSSB1 nor INTS3 displayed 
binding to INTS11, and, unlike hSSB1 and INTS3, INTS11 
coimmunoprecipitated INTS4, a member of the Integrator com-
plex which was not detected in hSSB1 MudPIT samples. The fail-
ure of INTS3 and -11 to coimmunoprecipitate each other may 
result from the bulk of INTS3 being sequestered in IMS1 instead of 
binding the Integrator complex, or it may reflect substoichiometric 
association of INTS3 with the Integrator complex. These data 
demonstrate that hSSB1 forms a complex with INTS3 and smaller 
amounts of ancillary Integrator subunit proteins, including INTS6, 
-5, and -1; alternatively, INTS6, -5, -8, and -1 may be only weakly 
associated with the core complex and lost during immunoprecipita-
tion and washing. Overall, the IMS1 complex appears distinct from 
the previously reported RNA polymerase II–associated complex 
carrying INTS11 catalytic activity (Baillat et al., 2005).
The presence of an additional, uncharacterized protein in 
the MudPIT analysis also suggested that the IMS1 complex is 
unique. To confirm the binding of MISE to hSSB1 and INTS3, 
Myc-tagged MISE was expressed in HEK293T cells, and immuno-
precipitations were performed for hSSB1, INTS3, and the Myc 
Figure 2.  INTS3–hSSB1 binding is independent of DNA damage and requires the hSSB1 OB fold. (A) NHFs were mock treated or treated with 2 µg/µl 
doxorubicin for 1.5 h before harvesting by sonication in lysis buffer containing benzonase. Lysates were immunoprecipitated for the indicated proteins, 
separated by SDS-PAGE, and Western blotted as indicated. (B) HEK293T cells were mock transfected or transfected with the following Flag-HA–tagged con-
structs: hSSB1, hSSB1 1–199, hSSB1 1–172, hSSB1 1–113, or hSSB2. 48 h after transfection, cells were harvested, and lysates were immunoprecipitated 
with anti-Flag (FL) M2 agarose, separated by SDS-PAGE, and Western blotted as indicated. Flag-HA-hSSB2–transfected samples were treated with 2 µg/µl 
doxorubicin 1 h before harvesting. (A and B) Molecular mass is indicated in kilodaltons. IP, immunoprecipitation; WCL, whole cell lysate; WT, wild type.JCB • VOLUME 187 • NUMBER 1 • 2009   28
recruited to DNA. Alternatively, similar to CHK2, INTS3 may 
be recruited transiently to irradiation-induced foci, making im-
mediate detection difficult (Lukas et al., 2003), but the unrepaired/ 
difficult to repair sites observed at late time points could 
stabilize this transient interaction, allowing detection of INTS3 
at these sites (Goodarzi et al., 2008). Additionally, hSSB1 could 
exist in two forms, one form (which does not bind INTS3) that 
is able to relocalize to foci and a second form that constitu-
tively binds INTS3. Finally, it remains possible that MISE but 
not INTS3 is capable of relocalizing to sites of DNA damage 
with hSSB1.
To  investigate  the  role  of  IMS1  in  controlling  hSSB1 
function, the DNA damage–induced localization of hSSB1 was 
examined after INTS3 knockdown by siRNA in NHFs (Fig. 3 A). 
Upon INTS3 knockdown, >75% of the cells examined failed to 
form hSSB1 foci after irradiation, demonstrating a role for IMS1 
in controlling hSSB1. This defect appears to reflect a depletion 
of hSSB1 levels, with a consequent deficiency in hSSB1 recruit-
ment to DNA damage sites (Fig. 3, A, C, and D). The ability of 
RAD51, a key component of the HR machinery, to form foci can 
be used as an indicator of DNA repair by HR, and hSSB1 has 
been shown to affect RAD51 foci formation (Richard et al., 
2008). To confirm that the observed effect on hSSB1 levels 
results in inhibition of the DNA damage response, the ability of 
RAD51 to localize to DNA damage–induced foci was examined 
after INTS3 knockdown. Consistent with the depletion of hSSB1, 
INTS3 knockdown cells exhibited severe defects in the recruit-
ment of RAD51 to DNA damage foci, with a 3.5-fold decrease 
in cells displaying RAD51 foci (Fig. 3 B). These results show 
that INTS3 regulates the recruitment of RAD51 to DNA breaks.
The effect of INTS3 depletion on hSSB1 and RAD51 DNA 
damage–induced  foci  suggested  that  IMS1  could  control  the 
global response to DNA damage. Previously, hSSB1 was demon-
strated to act as an upstream effector for ATM activation (Richard 
et al., 2008). To test whether IMS1 is required for ATM activation 
after DNA damage, NHFs were transfected with siRNAs target-
ing INTS3 and MISE and were subjected to either irradiation   
or doxorubicin treatment (Fig. 3, C and D). In control siRNA–
transfected cells, the response to DNA damage appeared normal, 
as assessed by ATM autophosphorylation and phosphorylation of 
downstream targets such as CHK2 and p53. In contrast, INTS3 or 
MISE knockdown cells displayed a dramatic decrease in ATM 
activation, with lower levels of CHK2 and p53 phosphorylation, 
which correlated with the degree of INTS3 or MISE depletion, 
indicating that IMS1 complex components are required for ATM 
activation. Moreover, INTS3 depletion affected ATM activation 
at early and late time points after irradiation (Fig. S3 A). Impor-
tantly, ATM and CHK2 activation was unaffected by INTS11 
knockdown, further suggesting that the IMS1 complex functions 
independently of the Integrator complex (Fig. S3 B).
INTS3 regulates the transcription  
of hSSB1
Depletion of INTS3 by siRNA results in decreased levels of 
hSSB1 (Fig. 3, C and D). In the absence of genotoxic stress, 
hSSB1 is relatively unstable (Richard et al., 2008), and the 
ability to codeplete INTS3 and hSSB1 suggested that the IMS1 
deletion mutants were expressed in HEK293T cells, and immuno-
precipitates were blotted for endogenous hSSB1 (Fig. S1 B). 
Although INTS3 mutants 1–675 and 1–512, containing an 
intact DUF2356 domain (PFAM domain of unknown function 
2356; Finn et al., 2008), were capable of coimmunoprecipitating 
hSSB1, truncations disrupting all or part of the domain were 
unable to bind hSSB1. Notably, this domain is strictly conserved 
in INTS3 orthologues.
In the reciprocal experiment, immunoprecipitation of hSSB1 
deletion mutants determined that the OB fold domain is sufficient 
for INTS3 binding, as hSSB1 1–113, containing only the OB fold, 
bound endogenous INTS3 (Fig. 2 B). The OB fold domains of 
hSSB1 and hSSB2 (an uncharacterized hSSB1 paralogue) are 
highly identical (>85%; Richard et al., 2008), and, as such, hSSB2 
also bound INTS3 (Fig. 2 B, last lane), suggesting that INTS3 and 
hSSB2 may form an analogous IMS2 complex. Because the OB 
fold domain mediates hSSB1 binding to DNA, these results imply 
that INTS3 may impede the binding of hSSB1 to DNA, poten-
tially regulating the relocalization of hSSB1 to foci after geno-
toxic stress. This result also suggests that INTS3 may not relocalize 
with hSSB1 to these foci. Finally, the strict conservation of the 
hSSB1 OB fold and the INTS3 DUF2356 further strengthens the 
notion that INTS3 binding is important for controlling the func-
tions of hSSB1.
INTS3 controls the hSSB1-mediated 
response to DNA damage
Many  DNA  damage  response  and  repair  proteins  rapidly   
relocalize to damaged DNA after genotoxic stress, forming discreet 
foci. Like other ATM pathway proteins, after DNA damage, 
hSSB1 rapidly relocalizes to sites of DNA damage (Richard   
et al., 2008). Although in analyses by immunoprecipitation and 
Western blotting the formation of the IMS1 complex appears 
unaffected by DNA damage, it was unknown whether INTS3 
and MISE play a role in the DNA damage–related functions of 
hSSB1. Therefore, the potential of INTS3 to form DNA damage 
foci, colocalizing with hSSB1 and other DNA damage response 
proteins, was investigated. In unextracted cells, endogenous   
INTS3 exhibited pan nuclear staining (not depicted), but after   
Triton X-100 extraction of nonchromatin-bound proteins, INTS3 
exhibited staining in discreet foci (Fig. S2). However, these foci 
were not DNA damage inducible and did not colocalize with   
either hSSB1 or -H2AX at damage-induced foci (Fig. S2, A and 
B), which form within minutes after DNA damage. At extended 
time points after irradiation (4 h), INTS3 did display a high 
degree of colocalization with -H2AX (Fig. S2 C), but the   
significance of relocalization at such a late time is unclear. INTS3 
also did not localize to a single double-strand break induced 
by I-SceI expression (Fig. S2 D; Pierce et al., 1999). These   
results are consistent with the binding of INTS3 to the OB fold 
of hSSB1, which may block the ability of hSSB1 to bind DNA, 
suggesting a potential role for the IMS1 complex in regulating 
the recruitment of hSSB1 to DNA after DNA damage. Such a role 
would also be consistent with the DNA damage–independent 
formation of the IMS1 complex; even after relocalization of a 
population of hSSB1 to foci, the complex could form with any 
available free hSSB1 that is either newly synthesized or not 29 IMS1 FUNCTIONS IN THE DNA DAMAGE RESPONSE • Skaar et al.
the ability of a constitutive promoter to uncouple hSSB1 from 
INTS3-based regulation was examined (Fig. 4, C and D; and 
Fig. S3, C and D). In cells expressing near-endogenous levels of 
hSSB1 from a retrovirus, INTS3 depletion failed to deplete ex-
ogenous hSSB1 or abrogate hSSB1 foci formation, confirming 
that the observed defects in hSSB1 levels and foci result from a 
defect in hSSB1 transcription. Furthermore, retrovirally ex-
pressed  hSSB1  rescued  RAD51  foci  formation  in  INTS3- 
depleted cells, demonstrating that the effect of INTS3 on RAD51 
foci is hSSB1 dependent (Fig. 4 E).
Our results demonstrate the existence of an IMS1 com-
plex, featuring a core of INTS3, MISE, and hSSB1 (or possibly 
hSSB2 in an IMS2 complex), with ancillary Integrator subunits 
complex may preserve a pool of hSSB1 from degradation in the 
absence of DNA damage to allow rapid activation of the DNA 
damage response. To test this hypothesis, hSSB1 stability was 
measured by determining its half-life in cycloheximide after 
INTS3 knockdown. In contrast to the predicted results, INTS3 
knockdown  severely  reduced  the  level  of  hSSB1  without   
decreasing the half-life of hSSB1 (Fig. 4 A).
Because  the  effect  of  INTS3  knockdown  on  hSSB1   
appeared largely degradation independent, the impact of INTS3 
on hSSB1 mRNA levels was examined (Fig. 4 B). Strikingly, 
INTS3 knockdown decreased hSSB1 mRNA levels by 90% 
versus  control  knockdown,  demonstrating  that  INTS3  likely 
controls hSSB1 transcription. To investigate this hypothesis, 
Figure 3.  INTS3 depletion blocks the hSSB1-mediated DNA damage response. (A) NHFs were transfected with a control (CTRL) siRNA or INTS3 siRNA #1   
before irradiation (6 Gy) and recovered for 1 h before staining for hSSB1 and DAPI. The top panel presents a representative field of ionizing radiation 
(IR)–treated cells, and the bottom panel shows the quantification of total results presented as mean ± SEM from three independent experiments. The inset 
shows a single cell enlarged. (B) NHFs were transfected with a control siRNA or INTS3 siRNA #1 before irradiation (6 Gy) and recovered for 3 h before 
staining for RAD51 and DAPI. The top panel presents a representative field of RAD51 foci in ionizing radiation–treated cells (deconvolved), and the bottom 
panel shows the quantification of total results presented as mean ± SEM from three independent experiments. (C) NHFs were transfected twice with the indi-
cated siRNAs. 72 h after transfection, cells were irradiated (7.5 Gy) and harvested 1 h after irradiation. Lysates were analyzed by SDS-PAGE and Western 
blotting (left) as indicated. Evaluation of MISE knockdown was performed using RT-PCR in triplicate (right). The mean values are shown plus or minus one 
standard deviation. (D) NHFs were transfected twice with the indicated siRNAs. 72 h after transfection, cells were treated with 2 µg/ml doxorubicin for 
1.5 h and harvested. Lysates were analyzed by SDS-PAGE and Western blotting as indicated.JCB • VOLUME 187 • NUMBER 1 • 2009   30
proteins in cancer and radiosensitivity syndromes, it is possible 
that pathogenic mutations in INTS3 or hSSB1 will be found. The 
IMS1 complex may also represent a target for chemotherapeutics 
that sensitize tumor cells to DNA-damaging treatments (Farmer 
et al., 2005). INTS3 is clearly required for an effective DNA dam-
age response, and further research into additional targets, bio-
chemical mechanisms, and potential roles in disease is required.
Materials and methods
Cell lines, transfection, and siRNAs
HEK293T  cells  were  maintained  in  DME  supplemented  with  10%   
bovine serum (Invitrogen), and all other cells (U-2 OS, MCF7, MCF7 
DR-GFP [gift from J. Jasin, Memorial Sloan-Kettering Cancer Center, New 
York, NY], and NHFs) were maintained in DME supplemented with 10%   
fetal bovine serum (Invitrogen). NHFs were either neonatal foreskin fibro-
blasts  (immunofluorescence  microscopy)  or  IMR90  (all  other  experi-
ments). MCF7 and HEK293T cells stably expressing Flag-hSSB1 were 
binding in a substoichiometric manner. IMS1 assembly is not 
regulated by ATM activation after DNA damage, suggesting 
that the ancillary members or other weak/transient interacting 
proteins may regulate the core complex’s role in the DNA dam-
age response. The role of these ancillary INTS proteins in the 
DNA damage response will require further examination.
Remarkably, in addition to binding hSSB1, INTS3 regu-
lates the abundance of hSSB1 at the transcriptional level. The 
formation of IMS1 coupled with this transcriptional regulation 
suggests the operation of a positive feedback loop in the DNA 
damage response. In such a model, INTS3 likely controls the 
cellular reserves of hSSB1 through the control of hSSB1 tran-
scription and possibly via physical sequestration.
The  INTS3–hSSB1  feedback  loop  establishes  a  new 
network in the control of the DNA damage response. Given the 
frequency of mutation of ATM and other DNA damage repair 
Figure 4.  INTS3 controls hSSB1 transcription. (A) NHFs were transfected twice with the indicated siRNAs. 72 h after transfection, cells were treated with 
cycloheximide (CHX) for the indicated time period. Lysates were analyzed by SDS-PAGE and Western blotting as indicated. (B) NHFs were transfected twice 
with the indicated siRNAs. 72 h after transfection, cells were harvested for preparation of mRNA and protein lysates. Western blotting was performed as 
indicated (left). RT-PCR for hSSB1 was performed in triplicate and is presented as the mean plus or minus one standard deviation (right). (A and B) Molecu-
lar mass is indicated in kilodaltons. (C) HEK293T cells stably expressing Flag (FL)-hSSB1 from a retroviral vector or HEK293T cells infected with an empty 
vector were transfected with LacZ siRNA or INTS3 siRNA #1 as indicated. 72 h after transfection, lysates were generated and analyzed by SDS-PAGE 
and Western blotting. Exogenous Flag-hSSB1 and endogenous hSSB1 are indicated. (D) MCF7 cells stably expressing Flag-hSSB1 from a retroviral vector 
or MCF7 cells infected with an empty vector were transfected with a control siRNA or INTS3 siRNA #1 before irradiation (6 Gy) and recovered for 1 h 
before staining for hSSB1 and DAPI. (E) MCF7 cells stably expressing Flag-hSSB1 from a retroviral vector or MCF7 cells infected with an empty vector were 
transfected with a control siRNA or INTS3 siRNA #1 before irradiation (6 Gy) and recovered for 1 h before staining for RAD51 and DAPI.31 IMS1 FUNCTIONS IN THE DNA DAMAGE RESPONSE • Skaar et al.
buffer was used for all subsequent washes. MudPIT of TCA-precipitated 
proteins was performed as previously described (Washburn et al., 2001; 
MacCoss et al., 2002; Florens and Washburn, 2006). Tandem mass 
spectra were interpreted using SEQUEST (Eng et al., 1994) against a 
database  of  61,430  sequences,  consisting  of  30,552  human  proteins 
(NCBI Protein database on March 4, 2008), 177 usual contaminants, 
and, to estimate false discovery rates, 30,712 randomized amino acid 
sequences derived from each nonredundant protein entry. Peptide/spectrum 
matches were sorted and selected using DTASelect (Tabb et al., 2002) with 
the following criteria set: spectra/peptide matches were only retained if 
they had a DeltCn of at least 0.08 and minimum XCorr of 1.8 for singly, 
2.5 for doubly, and 3.5 for triply charged spectra. Peptides had to be fully 
tryptic and at least 7 aa long, and positive identification required two 
unique peptides or one peptide with two independent spectra. The final 
false discovery rates at the protein and spectral levels were 1.9% and 0.14 ± 
0.085%, respectively. NSAFs were calculated for each detected protein 
(Florens et al., 2006; Paoletti et al., 2006; Zybailov et al., 2006).
Online supplemental material
Fig. S1 shows that DUF2356 is required for INTS3 binding to hSSB1. Fig. S2 
shows that INTS3 does not localize to irradiation-induced DNA damage 
sites. Fig. S3 shows that INTS3 but not INTS11 is required for proper ATM 
activation.  Online  supplemental  material  is  available  at  http://www 
.jcb.org/cgi/content/full/jcb.200907026/DC1.
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